Woo-Seob Shin

Introduction

Woo-Seob Shin, based in Gyeonggi-do, South Korea, stands out as an inventive mind in the pharmaceutical sector. With a total of 8 patents to his name, he has made significant strides in the field of medicinal chemistry, particularly in the development of selective inhibitors targeting specific protein kinases.

Latest Patents

Among his latest contributions is the patent for a process for preparing aminopyrimidine derivatives. This innovation outlines an improved approach for synthesizing aminopyrimidine derivatives or their pharmaceutically acceptable salts, which exhibit selective inhibitory activity against protein kinases. Specifically, the focus is on protein kinases associated with mutant epidermal growth factor receptors. Moreover, this invention also introduces novel intermediates essential for the described process and details methods for their preparation.

Career Highlights

Woo-Seob Shin is currently affiliated with Yuhan Corporation, a notable player in the pharmaceutical industry. His work is integral to the company's developments in drug formulation and therapeutic solutions, which emphasizes the importance of ongoing research and innovation in improving healthcare outcomes.

Collaborations

Throughout his career, Shin has collaborated with accomplished colleagues including Ja-Heouk Khoo and Hyun Ju. These partnerships have fostered a dynamic environment of idea exchange and innovation, further fueling advancements in their respective fields.

Conclusion

Woo-Seob Shin's contributions represent a significant asset to the pharmaceutical industry. His expertise and innovative processes underscore the vital role of inventors in advancing healthcare solutions. With each patent, he continues to pave the way for future advancements, reflecting the importance of ongoing research and collaboration in the realm of medicinal chemistry.